Accelerate research using platform and expertise developed in close collaboration with the National Institutes of Health
Vibrent seamlessly weaves participant-focused technologies into the entire life cycle of clinical research. Accelerate recruitment, retention and engagement of diverse populations and harmonize novel data collected - genotype, phenotype, medical and environmental context.
View use cases
Vibrent provides a robust, privacy preserving Digital Health Solutions Platform for clinical research in collaboration with the National Institutes of Health (NIH).
A data-first approach across the entire research lifecycle of outreach, awareness, recruitment, data collection, engagement and retention.
A single platform that replaces your multiple vendors
Approved by many IRBs
Fast deployment
000
M+000000
+
00
%+00000
+Whether you are competing for grants or pursuing new revenue; the keys to your success are generating novel datasets and recruiting, engaging and retaining diverse populations.
Make your budget go further. Workflow automation and digital marketing reduces labor costs. Robust virtual data collection methods helps you collect higher quality data sets at a lower cost. Cloud-based research tools drive efficiencies throughout the entire life cycle of your clinical research.
REQUEST A PILOT
One platform, one partner for your research needs. Co-developed with the NIH. Proven at with over 400,000 participants and over 1,000 study staff.
View ProductsOur team of subject matter experts will help you through every stage of the process. Need help with IRB submission, electronic consent design, EHR setup, remote sampling kits, selecting the right wearable and medical device technologies or recruitment/
retention/engagement strategies? We’re here for you.
Technology considerations to promote inclusion, equity and diversity in clinical research
Underrepresented groups traditionally were thought to have limited access to technology. But internet access is on the rise and researchers…
How Small Businesses Are Implementing Corporate Social Responsibility Missions
Small businesses have especially put emphasis on CSR-related challenges, issues and topics recently. Companies and organizations will often align their…
The Great Resignation & The Future Of Work: Matthew Mitchell Of Vibrent Health On How Employers and Employees Are Reworking Work Together
When it comes to designing the future of work, one size fits none. Discovering success isn’t about a hybrid model…
5 common social media mistakes in health research participant engagement
Social media continues to grow as a powerful tool for health researchers to recruit the right populations for their trials…
All of Us Research Program Releases Genomic Data to Researchers, Combined with Participant-Generated Data Collected on Vibrent Health’s Digital Health Research Platform
FAIRFAX, Va., March 18, 2022 – The National Institutes of Health’s All of Us Research Program has made its initial genomic dataset available,…
Vibrent Health to Launch Integrated Platform for Ancillary Studies in Large-Cohort Digital Health Research
FAIRFAX, Va.--March 1, 2022--Vibrent Health, a health technology startup powering the future of precision health research, announced the development of…
Why Diversity In Health Research Is Good Science And Good Business
Recruiting and retaining participants for clinical research — let alone those that represent diverse populations — has historically been a…
2022 predictions for AI and machine learning in healthcare
Praduman “PJ” Jain, CEO at Vibrent HealthInfectious disease research will use AI: As coronavirus becomes endemic and new pandemics emerge, it…
Vibrent Health powers NIH precision nutrition research project to accelerate discoveries in food and dietary patterns
FAIRFAX, Va., Jan. 20, 2022 – Vibrent Health, a health technology startup powering the future of precision health research, today…
Ethical AI can promote diversity in clinical research
In a clinical research ecosystem that’s not known for its diversity, AI brings something meaningful to the table — but…